Skip to main content

John P. Sefick

Securities Litigation and Shareholder Disputes

  • Represented publicly traded wellness company and its directors, defending against claims for securities fraud under sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and section 12 of the Securities Act of 1933, and common law claims for fraud, breach of fiduciary duty and breach of contract.
  • Represented publicly traded biotech company and its directors, defending against claims for securities fraud under section 10(b) and 20(a) of the Securities Exchange Act of 1934.
  • Represented publicly traded medical device company, defending against claims for breach of a securities purchase agreement.
  • Represented insurance company in appraisal rights action brought under Utah law.
  • Represented supermarket chain in appraisal rights action brought in Delaware.
  • Represented private investment firm, defending against claims for securities fraud under sections 11 and 15 of the Securities Act of 1933 and section 20(a) of the Securities Exchange Act of 1934.

Sports and Entertainment Law

  • Represented professional basketball player in arbitration with agent.
  • Represented professional basketball player agent in dispute with the Players’ Association.
  • Advised professional sports teams on a variety of issues, including employment disputes, internal investigations, and potential league discipline.

General Commercial Litigation

  • Represented global asset management company in arbitration proceeding, successfully litigating claims against former employees for breach of fiduciary duty, breach of contract, and fraud.
  • Represented individuals in Turnover Proceeding defending against claims of undue influence and fraudulent inducement.
  • Represented apparel company in putative class action relating to alleged product defects.
  • Represented reality television star in breach of contract and copyright litigation.

White Collar

  • Represented defrauded investor with respect to government investigation into alleged fraudulent entertainment app.

 

Case Study
Mintz represented XpresSpa Group, Inc. before the Second Circuit Court on appeal from the SDNY. Appellants sought to overturn the SDNY decision granting XpresSpa summary judgment and an earlier decision dismissing all of the appellants’ state law claims.
Case Study
Mintz secured dismissal of a securities fraud case against biopharmaceutical company Neurotrope. Mintz argued that securities laws do not require disclosure of the statistical methodology behind announced clinical trial results.